ACL Digital

Home / CaseStudy / Streamlined Vendor Management and Audit Preparedness for a Mid-sized CRO

Streamlined Vendor Management and Audit Preparedness for a Mid-sized CRO

Streamlined Vendor Management and Audit Preparedness for a Mid-sized CRO

CT banner Vandor Management

Overview

In clinical research, meticulous vendor management ensures compliance with regulatory standards and data integrity. ACL Digital Life Sciences assisted a mid-sized Contract Research Organization (CRO) when it faced a critical challenge. Several vendor re-qualifications were not completed as planned, posing a significant risk of non-compliance with regulatory requirements (ICH-GCP, FDA, EMA). With an impending sponsor audit, the CRO sought swift resolution to mitigate risks and uphold regulatory obligations.

Download Case Study








    Challenges

    Delayed vendor re-qualifications jeopardizing data integrity and regulatory compliance

    Impending sponsor audit necessitating swift resolution to demonstrate preparedness

    Need for a practical solution to address delays and mitigate compliance risks effectively

    Solution

    • Gap Analysis: A comprehensive analysis identified the root cause of the problem: a lack of risk-based prioritization within the re-qualification process
    • Risk-based Re-qualification: The existing vendor re-qualification process was revamped to prioritize critical andmajor risk vendors handling patient and clinical trial data. This ensured timely re-qualification for the most crucial vendors
    • Deviation Management: A detailed deviation list for delayed re-qualifications was prepared. This list assessed the impact of each delay and outlined corrective actions
    • Knowledge Transfer: A workshop equipped the CRO’s vendor management team with the revised process and immediate action items to address the upcoming sponsor audit. Additionally, long-term strategies for continuous improvement were discussed

    Outcomes

    Enhanced Compliance

    The risk-based re-qualification approach ensured adherence to regulatory requirements, mitigating the risk of non-compliance during Sponsor Audits

    Prioritizing critical vendors for re-qualification focused resources on the areas of highest risk, strengthening overall clinical trial integrity

    The updated re-qualification process with clear prioritization facilitated efficient vendor management

    The CRO was well-equipped to address potential audit findings with a comprehensive deviation list and corrective action plan

    Benefits Streamlined Vendor Management and Audit Preparedness for a Mid sized CRO
    Scroll to Top